Efficacy of CytoSorb®: a systematic review and meta-analysis

[1]  R. Bellomo,et al.  Hemoperfusion in the intensive care unit , 2022, Intensive Care Medicine.

[2]  J. Gummert,et al.  Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial , 2022, Circulation.

[3]  A. Zarbock,et al.  Is This the Beginning of the End of Cytokine Adsorption?* , 2022, Critical care medicine.

[4]  R. Schmid,et al.  Influence of extracorporeal cytokine adsorption on hemodynamics in severe acute pancreatitis: Results of the matched cohort pancreatitis cytosorbents inflammatory cytokine removal (PACIFIC) study. , 2022, Artificial organs.

[5]  K. Budde,et al.  CytoSorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open-Label, Randomized Controlled Pilot Study* , 2022, Critical care medicine.

[6]  C. Bode,et al.  Cytokine adsorption in patients with post-cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER) - a single-centre, open-label, randomised, controlled trial. , 2022, Resuscitation.

[7]  M. Schmoeckel,et al.  Hemoadsorption of Rivaroxaban and Ticagrelor during Acute Type A Aortic Dissection Operations , 2022, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[8]  D. Henzler,et al.  Therapeutic Modulation of the Host Defense by Hemoadsorption with CytoSorb®—Basics, Indications and Perspectives—A Scoping Review , 2021, International journal of molecular sciences.

[9]  A. Koch,et al.  Initial experience with CytoSorb therapy in patients receiving left ventricular assist devices. , 2021, Artificial organs.

[10]  M. Maggiorini,et al.  Cytokine adsorption in severe, refractory septic shock , 2021, Intensive Care Medicine.

[11]  C. Cecchetti,et al.  Role of Hemoperfusion With CytoSorb Associated With Continuous Kidney Replacement Therapy on Renal Outcome in Critically III Children With Septic Shock , 2021, Frontiers in Pediatrics.

[12]  F. Locatelli,et al.  Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children , 2021, Blood Purification.

[13]  U. Liebchen,et al.  Can the cytokine adsorber CytoSorb® help to mitigate cytokine storm and reduce mortality in critically ill patients? A propensity score matching analysis , 2021, Annals of Intensive Care.

[14]  Tobias Hübner,et al.  First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock , 2021, Journal of clinical medicine.

[15]  H. Niehaus,et al.  The effect of perioperative hemadsorption in patients operated for acute infective endocarditis - A randomized, controlled study. , 2021, Artificial organs.

[16]  A. Combes,et al.  Longitudinal Cytokine Profiling in Patients with Severe COVID-19 on Extracorporeal Membrane Oxygenation and Hemoadsorption , 2021, American Journal of Respiratory and Critical Care Medicine.

[17]  A. Galloway,et al.  Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation , 2021, ASAIO journal.

[18]  C. Bode,et al.  Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial , 2021, The Lancet Respiratory Medicine.

[19]  T. Luedde,et al.  Multicentric Castleman’s disease in HIV patients: a single-center cohort diagnosed from 2008 to 2018 , 2021, Infection.

[20]  J. Kellum,et al.  Effect of Cytokine Adsorption on Survival and Circulatory Stabilization in Patients Receiving Extracorporeal Cardiopulmonary Resuscitation , 2021, ASAIO journal.

[21]  E. Roman-Pognuz,et al.  Effects of tocilizumab versus hemoadsorption combined with tocilizumab in patients with SARS-CoV-2 pneumonia: Preliminary results , 2021, The International journal of artificial organs.

[22]  A. Hollinger,et al.  Hemoadsorption during Cardiopulmonary Bypass in Patients with Endocarditis Undergoing Valve Surgery: A Retrospective Single-Center Study , 2021, Journal of clinical medicine.

[23]  U. Liebchen,et al.  Blood purification with a cytokine adsorber for the elimination of myoglobin in critically ill patients with severe rhabdomyolysis , 2021, Critical Care.

[24]  Christina Scharf,et al.  Charakteristika und Outcome von 70 beatmeten COVID-19-Patienten , 2020, Der Anaesthesist.

[25]  C. Ince,et al.  Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis , 2020, Blood Purification.

[26]  D. Fries,et al.  Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective ‘Genetic’ Matched Analysis , 2020, Biomedicines.

[27]  P. Metnitz,et al.  Adsorption therapy in critically ill with septic shock and acute kidney injury: a retrospective and prospective cohort study , 2020, Annals of Intensive Care.

[28]  R. Bruno,et al.  Hemoperfusion with CytoSorb as Adjuvant Therapy in Critically Ill Patients with SARS-CoV2 Pneumonia , 2020, Blood Purification.

[29]  C. Bode,et al.  Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation. , 2020, ASAIO journal.

[30]  J. Bauersachs,et al.  Early use of hemoadsorption in patients after out-of hospital cardiac arrest – a matched pair analysis , 2020, PloS one.

[31]  Y. Mehta,et al.  Modulating the Inflammatory Response With Hemadsorption (CytoSorb) in Patients Undergoing Major Aortic Surgery. , 2020, Journal of cardiothoracic and vascular anesthesia.

[32]  Amber Dance.  What is a cytokine storm? , 2020 .

[33]  Stefan Fischer,et al.  Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis , 2020, The Thoracic and Cardiovascular Surgeon.

[34]  Z. Bosnić,et al.  Extracorporeal Hemadsorption versus Glucocorticoids during Cardiopulmonary Bypass: A Prospective, Randomized, Controlled Trial , 2020, Cardiovascular therapeutics.

[35]  M. Neuhäuser,et al.  Intraoperative hemoadsorption in patients with native mitral valve infective endocarditis. , 2020, The Annals of thoracic surgery.

[36]  J. Coselli,et al.  Hemoadsorption to Reduce Plasma Free Hemoglobin during Cardiac Surgery: Results of REFRESH I Pilot Study. , 2019, Seminars in thoracic and cardiovascular surgery.

[37]  P. Souček,et al.  Plasma Levels of Myocardial MicroRNA-133a Increase by Intraoperative Cytokine Hemoadsorption in the Complex Cardiovascular Operation , 2019, Journal of clinical medicine research.

[38]  M. Luehr,et al.  Haemadsorption improves intraoperative haemodynamics and metabolic changes during aortic surgery with hypothermic circulatory arrest. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[39]  C. Ince,et al.  Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study , 2019, Critical Care.

[40]  J. Hartmann,et al.  Cytokine Removal in Extracorporeal Blood Purification: An in vitro Study , 2019, Blood Purification.

[41]  M. Schmoeckel,et al.  Cytosorb Adsorption During Emergency Cardiac Operations in Patients at High Risk of Bleeding. , 2019, The Annals of thoracic surgery.

[42]  C. Zöllner,et al.  Hemadsorption during cardiopulmonary bypass reduces interleukin 8 and tumor necrosis factor α serum levels in cardiac surgery: a randomized controlled trial. , 2019, Minerva anestesiologica.

[43]  L. Alberio,et al.  Cytokine clearance with CytoSorb® during cardiac surgery: a pilot randomized controlled trial , 2019, Critical Care.

[44]  Z. Molnár,et al.  Extracorporeal cytokine adsorption in septic shock: A proof of concept randomized, controlled pilot study , 2019, Journal of critical care.

[45]  J. Roberts,et al.  In vitro removal of anti-infective agents by a novel cytokine adsorbent system , 2018, The International journal of artificial organs.

[46]  A. Lee,et al.  ESICM LIVES 2018 , 2018, Intensive Care Medicine Experimental.

[47]  Russell Steele,et al.  Meta‐analysis of the difference of medians , 2018, Biometrical journal. Biometrische Zeitschrift.

[48]  B. Merkely,et al.  Impact of intraoperative cytokine adsorption on outcome of patients undergoing orthotopic heart transplantation—an observational study , 2018, Clinical transplantation.

[49]  J. Kellum,et al.  The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: A randomized controlled trial , 2017, PloS one.

[50]  P. Pelosi,et al.  ESICM LIVES 2017 , 2017, Intensive Care Medicine Experimental.

[51]  K. Träger,et al.  Hemoadsorption Treatment of Patients with Acute Infective Endocarditis during Surgery with Cardiopulmonary Bypass - A Case Series , 2017, The International journal of artificial organs.

[52]  Hester F. Lingsma,et al.  37th International Symposium on Intensive Care and Emergency Medicine (part 3 of 3) , 2017, Critical Care.

[53]  A. Spittler,et al.  Effect of hemoadsorption during cardiopulmonary bypass surgery – a blinded, randomized, controlled pilot study using a novel adsorbent , 2016, Critical Care.

[54]  Tiejun Tong,et al.  Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range , 2015, Statistical methods in medical research.

[55]  D. Falkenhagen,et al.  Pore Size – a Key Property for Selective Toxin Removal in Blood Purification , 2014, The International journal of artificial organs.

[56]  J. Kellum,et al.  Blood Purification and Mortality in Sepsis: A Meta-Analysis of Randomized Trials* , 2013, Critical care medicine.

[57]  C. Putensen,et al.  A multicenter randomized controlled study of an extracorporeal cytokine hemoadsorption device in septic patients , 2013, Critical Care.

[58]  John A Kellum,et al.  Clinical review: Blood purification for sepsis , 2011, Critical care.

[59]  C. Coopersmith,et al.  The systemic inflammatory response syndrome. , 2006, Microbes and infection.

[60]  Charles Natanson,et al.  Novel therapies for sepsis: a review. , 2005, The Journal of trauma.

[61]  John A Kellum,et al.  Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-&kgr;B DNA binding, and improves short-term survival in lethal endotoxemia* , 2004, Critical care medicine.

[62]  P. Honore,et al.  Extracorporeal removal for sepsis: Acting at the tissue level--the beginning of a new era for this treatment modality in septic shock. , 2004, Critical care medicine.

[63]  E. Barzilay,et al.  Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. , 1989, Critical care medicine.

[64]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..